In addition to these effects on maintaining phosphate homeostasis, several studies have shown an association between FGF23 and cardiac hypertrophy and/or left ventricular dysfunction in various populations such as patients with chronic kidney disease (CKD) [7,8], elderly individuals [9], and those undergoing maintenance hemodialysis [10,11]. This evidence concerns the gene FGF23 and cardiac hypertrophy.